{"entity":{"type":"insider","cik":"0001798443","url":"/insider/0001798443","json_url":"/insider/0001798443.json","name":"Kalif Eliyahu Sharon","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":8,"n_filings":8,"first":"2022-08-24","last":"2026-06-16","span_basis":"filed_date"},"name_variants":[{"name":"Kalif Eliyahu Sharon","source":"filing","n_filings":8,"first_seen":"2022-08-24","last_seen":"2026-06-16"}],"transactions":[{"id":6006033,"accession":"0001193125-26-271862","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193125-26-271862","line_url":"/filing/0001193125-26-271862#line-1","is_derivative":false,"issuer_cik":"0000818686","issuer_name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","issuer_ticker":"TEVA","issuer_name_source":null,"issuer_url":"/issuer/0000818686","owner_cik":"0001798443","owner_name":"Kalif Eliyahu Sharon","owner_display_name":"Kalif Eliyahu Sharon","owner_url":"/insider/0001798443","role":"Officer (EVP, Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Financial Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":106563.0,"shares_display":"106,563","price_per_share":34.0954,"price_display":"34.10","price_state":"stated","total_value":3633308.1102,"total_display":"3,633,308.11","total_whole":"3,633,308","shares_owned_after":65621.0,"shares_owned_after_display":"65,621","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-06-11","filed_date":"2026-06-16","scope":"insider"},{"id":5751127,"accession":"0001193125-26-228870","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193125-26-228870","line_url":"/filing/0001193125-26-228870#line-1","is_derivative":false,"issuer_cik":"0000818686","issuer_name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","issuer_ticker":"TEVA","issuer_name_source":null,"issuer_url":"/issuer/0000818686","owner_cik":"0001798443","owner_name":"Kalif Eliyahu Sharon","owner_display_name":"Kalif Eliyahu Sharon","owner_url":"/insider/0001798443","role":"Officer (EVP, Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Financial Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":153251.0,"shares_display":"153,251","price_per_share":35.6107,"price_display":"35.61","price_state":"stated","total_value":5457375.3857,"total_display":"5,457,375.39","total_whole":"5,457,375","shares_owned_after":172184.0,"shares_owned_after_display":"172,184","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-05-14","filed_date":"2026-05-18","scope":"insider"},{"id":5884032,"accession":"0001193125-26-085343","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193125-26-085343","line_url":"/filing/0001193125-26-085343#line-1","is_derivative":false,"issuer_cik":"0000818686","issuer_name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","issuer_ticker":"TEVA","issuer_name_source":null,"issuer_url":"/issuer/0000818686","owner_cik":"0001798443","owner_name":"Kalif Eliyahu Sharon","owner_display_name":"Kalif Eliyahu Sharon","owner_url":"/insider/0001798443","role":"Officer (EVP, Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Financial Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":345810.0,"shares_display":"345,810","price_per_share":33.6448,"price_display":"33.64","price_state":"stated","total_value":11634708.288,"total_display":"11,634,708.29","total_whole":"11,634,708","shares_owned_after":57478.0,"shares_owned_after_display":"57,478","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-02-26","filed_date":"2026-03-02","scope":"insider"},{"id":4983067,"accession":"0000950170-25-086697","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-25-086697","line_url":"/filing/0000950170-25-086697#line-1","is_derivative":false,"issuer_cik":"0000818686","issuer_name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","issuer_ticker":"TEVA","issuer_name_source":null,"issuer_url":"/issuer/0000818686","owner_cik":"0001798443","owner_name":"Kalif Eliyahu Sharon","owner_display_name":"Kalif Eliyahu Sharon","owner_url":"/insider/0001798443","role":"Officer (EVP, Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Financial Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":55775.0,"shares_display":"55,775","price_per_share":17.0769,"price_display":"17.08","price_state":"stated","total_value":952464.0975,"total_display":"952,464.10","total_whole":"952,464","shares_owned_after":403288.0,"shares_owned_after_display":"403,288","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-06-12","filed_date":"2025-06-16","scope":"insider"},{"id":4615979,"accession":"0000950170-25-031946","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-25-031946","line_url":"/filing/0000950170-25-031946#line-1","is_derivative":false,"issuer_cik":"0000818686","issuer_name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","issuer_ticker":"TEVA","issuer_name_source":null,"issuer_url":"/issuer/0000818686","owner_cik":"0001798443","owner_name":"Kalif Eliyahu Sharon","owner_display_name":"Kalif Eliyahu Sharon","owner_url":"/insider/0001798443","role":"Officer (EVP, Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Financial Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":55750.0,"shares_display":"55,750","price_per_share":16.2056,"price_display":"16.21","price_state":"stated","total_value":903462.2,"total_display":"903,462.20","total_whole":"903,462","shares_owned_after":147941.0,"shares_owned_after_display":"147,941","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-02-28","filed_date":"2025-03-04","scope":"insider"},{"id":3072506,"accession":"0000950170-24-028015","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000950170-24-028015","line_url":"/filing/0000950170-24-028015#line-3","is_derivative":false,"issuer_cik":"0000818686","issuer_name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","issuer_ticker":"TEVA","issuer_name_source":null,"issuer_url":"/issuer/0000818686","owner_cik":"0001798443","owner_name":"Kalif Eliyahu Sharon","owner_display_name":"Kalif Eliyahu Sharon","owner_url":"/insider/0001798443","role":"Officer (EVP, Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Financial Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":77550.0,"shares_display":"77,550","price_per_share":13.5154,"price_display":"13.52","price_state":"stated","total_value":1048119.27,"total_display":"1,048,119.27","total_whole":"1,048,119","shares_owned_after":203691.0,"shares_owned_after_display":"203,691","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-06","filed_date":"2024-03-07","scope":"insider"},{"id":8582839,"accession":"0001209191-23-045156","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-045156","line_url":"/filing/0001209191-23-045156#line-1","is_derivative":false,"issuer_cik":"0000818686","issuer_name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","issuer_ticker":"TEVA","issuer_name_source":null,"issuer_url":"/issuer/0000818686","owner_cik":"0001798443","owner_name":"Kalif Eliyahu Sharon","owner_display_name":"Kalif Eliyahu Sharon","owner_url":"/insider/0001798443","role":"Officer (EVP, Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Financial Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":35125.0,"shares_display":"35,125","price_per_share":9.7335,"price_display":"9.73","price_state":"stated","total_value":341889.1875,"total_display":"341,889.19","total_whole":"341,889","shares_owned_after":99162.0,"shares_owned_after_display":"99,162","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-08-07","filed_date":"2023-08-09","scope":"insider"},{"id":6517553,"accession":"0001209191-22-047291","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-047291","line_url":"/filing/0001209191-22-047291#line-1","is_derivative":false,"issuer_cik":"0000818686","issuer_name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","issuer_ticker":"TEVA","issuer_name_source":null,"issuer_url":"/issuer/0000818686","owner_cik":"0001798443","owner_name":"Kalif Eliyahu Sharon","owner_display_name":"Kalif Eliyahu Sharon","owner_url":"/insider/0001798443","role":"Officer (EVP, Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Financial Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":55500.0,"shares_display":"55,500","price_per_share":10.0666,"price_display":"10.07","price_state":"stated","total_value":558696.3,"total_display":"558,696.30","total_whole":"558,696","shares_owned_after":9376.0,"shares_owned_after_display":"9,376","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-08-22","filed_date":"2022-08-24","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":8,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":8,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":8},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0000818686","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","url":"/issuer/0000818686","role":"Officer (EVP, Chief Financial Officer)","n_filings":8,"first_seen":"2022-08-24","last_seen":"2026-06-16"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001798443","retrieved_at":"2026-08-24T14:54:01+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}